4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000816
Chief Scientific Officer bought 3,599 shares at $2.28 ($8,199)
From the SEC's structured data for this filing
Trades in this filing
NEIL GARRY ARTHUR · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-10 | Purchase : show line 1 in the form | +3,599 | $2.28 | $8,199 | 77,680 | D |
| Open-market purchases · 3,599 sh · avg $2.28 · $8,199 | ||||||
Loading xslF345X03/edgar.xml…